Sofinnova Investments, Inc. Fulcrum Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 15, 2024	BUY	$3.18 - $6.86 $90,948 - $196,196	28,600 New	28,600 $193,000
Q4 2023 Feb 12, 2024	BUY	$3.18 - $6.86 $90,948 - $196,196	28,600 New	28,600 $193,000
Q4 2022 Feb 13, 2023	SELL	$5.01 - $8.35 $830,913 - $1.38 Million	-165,851 Reduced 20.8%	631,411 $4.6 Million
Q3 2022 Nov 08, 2022	BUY	$4.92 - $9.1 $3.92 Million - $7.26 Million	797,262 New	797,262 $6.45 Million
Q2 2022 Aug 15, 2022	SELL	$4.2 - $24.0 $963,937 - $5.51 Million	-229,509 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.96 - $23.65 $3.87 Million - $9.18 Million	-388,161 Reduced 62.84%	229,509 $5.43 Million
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $7.93 Million - $16.1 Million	566,664 Added 1110.98%	617,670 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $371,323 - $1.58 Million	51,006 New	51,006 $1.44 Million

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.